Genetic evidence for efficacy of targeting IL-2, IL-6 and TYK2 signalling in the prevention of type 1 diabetes: a Mendelian randomisation study. - Heikkilä TE; Kaiser EK; Lin J; Gill D; Koskenniemi JJ; Karhunen V (Diabetologia, 2024)